Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Thoracic Cancer|May 2, 2022
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterationsYuji Uehara, Kageaki Watanabe, Taiki Hakozaki, et al.
JTO Clinical and Research Reports|July 17, 2023
Successful Treatment of ALK-Positive Large-Cell Neuroendocrine Carcinoma of the Lung With Sequential ALK Inhibitors: A Case ReportTakayuki Kobayashi, Yuji Uehara, Kageaki Watanabe, et al.
Internal Medicine (Tokyo, Japan)|June 8, 2018
Aspergillus Sternomyelitis Developed from Chronic Pulmonary Aspergillosis as a Late Complication to Lobectomy for Lung CancerYuji Uehara, Hajime Kasai, Takahiro Nakajima, et al.
Proteins|December 7, 2018
High-resolution crystal structure of peptidyl-tRNA hydrolase from Thermus thermophilusAmi Matsumoto, Yuji Uehara, Yoshihiro Shimizu, et al.
Thoracic Cancer|December 27, 2024
EGFR, TP53, and CUL3 Triple Mutation in Non-Small Cell Lung Cancer and its Potentially Poor Prognosis: A Case Report and Database AnalysisHiroto Hatano, Tatsuya Yoshida, Ryoko Higashiyama, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2026
Real-world clinical characteristics and outcomes in patients with HER2-mutant non-small cell lung cancer (NSCLC) who received second-line treatment: A nationwide database analysis in JapanYuji Uehara, Masachika Ikegami, Shinji Kohsaka, et al.
International Journal of Clinical Oncology|November 30, 2023
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapyYuto Terashima, Taiki Hakozaki, Yuji Uehara, et al.
JTO Clinical and Research Reports|April 10, 2024
Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLCTsuyoshi Hirata, Yuji Uehara, Taiki Hakozaki, et al.
JTO Clinical and Research Reports|January 6, 2025
Corrigendum to 'Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC' [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]Tsuyoshi Hirata, Yuji Uehara, Taiki Hakozaki, et al.
Journal of Thoracic Disease|September 13, 2024
Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinomaXiaojian Shen, Jing Xie, Shu Liu, et al.
Pageof 3